1. Home
  2. SLGL vs LGCB Comparison

SLGL vs LGCB Comparison

Compare SLGL & LGCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • LGCB
  • Stock Information
  • Founded
  • SLGL 1997
  • LGCB 2011
  • Country
  • SLGL Israel
  • LGCB Japan
  • Employees
  • SLGL N/A
  • LGCB N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • LGCB
  • Sector
  • SLGL Health Care
  • LGCB
  • Exchange
  • SLGL Nasdaq
  • LGCB Nasdaq
  • Market Cap
  • SLGL 19.3M
  • LGCB 19.2M
  • IPO Year
  • SLGL 2018
  • LGCB 2023
  • Fundamental
  • Price
  • SLGL $13.00
  • LGCB $2.54
  • Analyst Decision
  • SLGL Buy
  • LGCB
  • Analyst Count
  • SLGL 1
  • LGCB 0
  • Target Price
  • SLGL $40.00
  • LGCB N/A
  • AVG Volume (30 Days)
  • SLGL 13.9K
  • LGCB 7.2K
  • Earning Date
  • SLGL 08-15-2025
  • LGCB 07-03-2025
  • Dividend Yield
  • SLGL N/A
  • LGCB N/A
  • EPS Growth
  • SLGL N/A
  • LGCB N/A
  • EPS
  • SLGL N/A
  • LGCB N/A
  • Revenue
  • SLGL $12,103,000.00
  • LGCB $8,993,265.00
  • Revenue This Year
  • SLGL N/A
  • LGCB N/A
  • Revenue Next Year
  • SLGL $31.17
  • LGCB N/A
  • P/E Ratio
  • SLGL N/A
  • LGCB N/A
  • Revenue Growth
  • SLGL 603.66
  • LGCB 5.80
  • 52 Week Low
  • SLGL $3.34
  • LGCB $1.22
  • 52 Week High
  • SLGL $16.50
  • LGCB $30.65
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 87.12
  • LGCB 51.21
  • Support Level
  • SLGL $10.95
  • LGCB $2.63
  • Resistance Level
  • SLGL $12.90
  • LGCB $2.77
  • Average True Range (ATR)
  • SLGL 1.12
  • LGCB 0.08
  • MACD
  • SLGL 0.40
  • LGCB -0.00
  • Stochastic Oscillator
  • SLGL 95.73
  • LGCB 51.06

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

Share on Social Networks: